Ponatinib N-oxide

SL-9801

Ponatinib N-oxide, >98%

CAS No. : [2227480-51-3]

IUPAC Name : 4-(4-(3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzamido)-2-(trifluoromethyl)benzyl)-1-methylpiperazine 1-oxide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a minor and inactive metabolite of Ponatinib, which is a multi-targeted kinase inhibitor (TKI). Ponatinib is used to treat certain types of leukemia.

References : O'Hare T. et al.: Cancer Cell 16(5), 401-412, 2009; Gozgit J. M. et al.: Mol Cancer Ther., 10(6), 1028-1035, 2011; Uchida T. et al.: Exp Hematol., 42(5), 369-379, 2014.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.